ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MSYS Microsaic Systems Plc

1.12
0.07 (6.67%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00BMWC8365 ORD GBP0.00001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.07 6.67% 1.12 1.00 1.10 1.05 1.00 1.05 718,528 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Components, Nec 1.57M -2.29M -0.0128 -0.82 1.88M
Microsaic Systems Plc is listed in the Electronic Components sector of the London Stock Exchange with ticker MSYS. The last closing price for Microsaic Systems was 1.05p. Over the last year, Microsaic Systems shares have traded in a share price range of 1.00p to 17,578.125p.

Microsaic Systems currently has 179,178,184 shares in issue. The market capitalisation of Microsaic Systems is £1.88 million. Microsaic Systems has a price to earnings ratio (PE ratio) of -0.82.

Microsaic Systems Share Discussion Threads

Showing 3301 to 3323 of 4550 messages
Chat Pages: Latest  134  133  132  131  130  129  128  127  126  125  124  123  Older
DateSubjectAuthorDiscuss
17/9/2019
12:36
Probably Miton selling.
k1ngkonggb
17/9/2019
12:35
Mm's must love these desperate sellers that bail miles below the bid
dave4545
16/9/2019
16:43
Hopefully NYB. I’ll repeat what I said two weeks ago here:


bones 4 Sep '19 - 09:17 - 417 of 438

I am expecting a thumping loss as usual given the R&D spend but want to see progress in the stated aim of getting toward breakeven at the basic level (on which recent share options to directors were partially targeted). As NY Boy says, this is not an overnight expectation.

Also want to see updates on sales following the numerous distribution channels that have been signed up in the last couple of years. The CEO is hanging his hat on those helping sales of the standard products along (the 4500 and Protein-ID).

Finally, any sign of traction in the biologics field would be pleasant!


bones4 Sep '19 - 09:47 - 418 of 438

Back in May (5 months into the interim period) at the AGM, the company said:

“Orders received in the Year to Date have been significantly above orders received by the Company in the whole of the first half of 2018.

During the period the Company launched its breakthrough protein characterisation product, MiD(R) ProteinID, which can measure both small and large molecules simultaneously at the point of need. Subsequently on 5 March 2019, the Company announced its joint publication with the Massachusetts Institute of Technology ("MIT") showcasing ProteinID's capabilities in measuring the effects of storage on biopharmaceutical feedstocks.”

Let’s hope this translated into strong sales growth and that the period from July to September has continued to show such progress.

bones
16/9/2019
13:17
Results next Monday, expecting a decent report and update.

Hopefully 2p + soon imo

ny boy
11/9/2019
15:40
Here we go again, will the buyer take up the dip again ?
dave4545
10/9/2019
16:06
Yes, 1.6 seems to be a pivot point where both sellers and buyers kick in.
bones
10/9/2019
16:04
We seem to have a battle on atm
dave4545
09/9/2019
22:44
Agree, it's funny how stocks kick off the hour you go offline. You sit there all day all week watching and nothing happens.
dave4545
09/9/2019
14:52
Yes, it’s the old issue of original buyers at 1.7 selling when the price gets them almost back to where they bought so they sell to minimise the loss. Now it is a resistance level. Once it pushes through with significant volume, we may get lift off.
bones
09/9/2019
13:22
If i'd not noticed the volume I would not have noticed we spiked up and back down a short while ago on good volumes.
dave4545
07/9/2019
11:53
NYB, for sure. Will be instructive to see what they say on 23rd September.

Hopefully, (1) solid sales growth, (2) geographic impacts by their numerous new distributors, (3) some kind of headway with biologics discussions.

bones
07/9/2019
00:23
Just got to remain patient with these tiddlers
ny boy
05/9/2019
16:28
And it was 1.6p bid yesterday, 1.42p is £300 less too
dave4545
05/9/2019
16:27
Presumably chasing the next big thing? Seems daft when MSYS has not updated the market since that day.
bones
05/9/2019
16:22
wow they held all that time just to sell now for that loss.
dave4545
05/9/2019
16:21
Another punter from the big volume day in June has thrown in the towel for a 15% loss.
bones
05/9/2019
14:28
Assume a publishing glitch seeing as they were the same trades published yesterday and have reappeared today twice over.
bones
05/9/2019
11:43
Whole load of previous trades showing up this morning

Onwards & upwards

ny boy
04/9/2019
22:57
Just an accumulation stock, not bothered who is buy or selling now, just a few small time traders.

Think long term, like I have done with (STX) since 30p’s

Knowing, you are quiet, sold out already, think long term, just hold for a few years. Either that or you are lazying on holiday and over indulging still.

ny boy
04/9/2019
12:12
0.2p spread online now shocking

1.425-1.625p

dave4545
04/9/2019
11:12
And as usual, the minute you get momentum, a couple of snowflakes sell up. It happened today on AOR too. When will they understand you have to ride momentum to make any money!
bones
04/9/2019
10:41
nice rise and interest today.

When I checked in at 7.30am I thought nothing would happen and went back to sleep

dave4545
04/9/2019
09:47
Back in May (5 months into the interim period) at the AGM, the company said:

“Orders received in the Year to Date have been significantly above orders received by the Company in the whole of the first half of 2018.

During the period the Company launched its breakthrough protein characterisation product, MiD(R) ProteinID, which can measure both small and large molecules simultaneously at the point of need. Subsequently on 5 March 2019, the Company announced its joint publication with the Massachusetts Institute of Technology ("MIT") showcasing ProteinID's capabilities in measuring the effects of storage on biopharmaceutical feedstocks.”

Let’s hope this translated into strong sales growth and that the period from July to September has continued to show such progress.

bones
Chat Pages: Latest  134  133  132  131  130  129  128  127  126  125  124  123  Older

Your Recent History

Delayed Upgrade Clock